Could the hand-foot syndrome after capecitabine treatment be associated with better outcome in metastatic breast cancer patients?

By Kurt Mevlut   Aksoy Sercan   Guler Nilufer  

Acta Oncologica, Vol. 45, Iss. 5, 2006-07 ,pp. : 625-626

Informa Healthcare

Access to resources Recommend Favorite

Hypertriglyceridemia in patients with metastatic breast cancer and treatment with capecitabine

By Geva Shahar   Lazarev Irena   Geffen David Barry   Ariad Samuel  

Journal of Chemotherapy, Vol. 25, Iss. 3, 2013-06 ,pp. : 176-180

Maney Publishing

Access to resources Recommend Favorite

Oral capecitabine in anthracycline- and taxane-pretreated advanced/metastatic breast cancer

By Wist Erik   Sommer Hilde   Østenstad Bjørn   Risberg Terje   Bremnes Yngve   Mjaaland Ingvild  

Acta Oncologica, Vol. 43, Iss. 2, 2004-03 ,pp. : 186-189

Informa Healthcare

Access to resources Recommend Favorite

Capecitabine monotherapy in patients with anthracycline-and taxane-pretreated metastatic breast cancer

By Lee S.-H.   Lee J.   Park J.   Park S.   Lee K.-E.   Lee S.   Nam E.   Park J.   Kim K.   Jung C.   Park Y.   Yoon S.   Kang W.   Lee M.   Park K.   Im Y.-H.  

Medical Oncology, Vol. 21, Iss. 3, 2004-09 ,pp. : 223-231

Humana Press, Inc

Access to resources Recommend Favorite

Phase II Study of Capecitabine in Combination With Thalidomide in Patients With Metastatic Breast Cancer

By Burris Howard A.   Jones Suzanne F.   Shipley Dianna   Meluch Anthony A.   Greco F. Anthony   Barton John H.   Yardley Denise A.   Hainsworth John D.  

Cancer Investigation, Vol. 28, Iss. 4, 2010-04 ,pp. : 408-412

Informa Healthcare

Access to resources Recommend Favorite